Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis)
- PMID: 20126505
- PMCID: PMC2814576
Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis)
Abstract
The purpose of this study was twofold: first, to prospectively compare visual acuity (VA) scores obtained with Snellen charts versus Early Treatment Diabetic Retinopathy Study (ETDRS) charts in a "real world" retinal practice, and second, to see if there was a difference in visual acuity measurements obtained with ETDRS charts starting at 4 or 2 meters.
Methods: Prospective, consecutive evaluation of patients who underwent best-corrected visual acuity testing of their right eye performed at a single seating by the same experienced, certified vision examiner in the same room with standardized low light conditions using a projected Snellen chart at 20 feet, and two different back-illuminated ETDRS charts placed 4 and 2 meters from the patient.
Results: One hundred sixty-three eyes were included in the study. The mean Snellen VA was 0.67 logMAR (20/94), ETDRS VA at 4 meters was 0.54 logMAR (~20/69), and ETDRS VA at 2 meters was 0.51 logMAR (~20/65). The mean difference was 6.5 letters better on the ETDRS chart (P=.000000001). As the VA worsened, there was increased variability between the charts and the mean discrepancy between charts also increased. Subgroup analysis revealed the greatest difference between charts was in the poor vision subgroup (<20/200) with a difference of 0.2 logMAR (10 letters; P=.0000002). Patients with exudative age-related macular degeneration (AMD) had the greatest disparity on vision testing, but patients with dry AMD and diabetic retinopathy also exhibited significant differences.
Conclusions: Visual acuity scores were significantly better on ETDRS charts compared to Snellen charts. The difference was greatest with poor visual acuity (<20/200) and in patients with exudative AMD. Thus, caution should be exercised when comparing data using the different charts.
Figures








Similar articles
-
Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts.Ophthalmology. 2008 Feb;115(2):319-23. doi: 10.1016/j.ophtha.2007.05.028. Epub 2007 Aug 13. Ophthalmology. 2008. PMID: 17706288 Free PMC article.
-
Visual Acuity Variability: Comparing Discrepancies between Snellen and ETDRS Measurements among Subjects Entering Prospective Trials.Ophthalmol Retina. 2021 Mar;5(3):224-233. doi: 10.1016/j.oret.2020.04.011. Epub 2020 Apr 23. Ophthalmol Retina. 2021. PMID: 32595096
-
Repeatability and Agreement of Visual Acuity Using the ETDRS Number Chart, Landolt C Chart, or ETDRS Alphabet Chart in Eyes With or Without Sight-Threatening Diseases.JAMA Ophthalmol. 2018 Mar 1;136(3):286-290. doi: 10.1001/jamaophthalmol.2017.6290. JAMA Ophthalmol. 2018. PMID: 29346499 Free PMC article.
-
Is your vision blurry? A systematic review of home-based visual acuity for telemedicine.J Telemed Telecare. 2023 Feb;29(2):81-90. doi: 10.1177/1357633X20970398. Epub 2020 Nov 22. J Telemed Telecare. 2023. PMID: 33222600
-
Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies.Adv Ther. 2020 Jan;37(1):300-315. doi: 10.1007/s12325-019-01147-6. Epub 2019 Nov 14. Adv Ther. 2020. PMID: 31728825 Free PMC article.
Cited by
-
Visual Acuity Examination Methodology in Keratoconus.J Clin Med. 2023 Dec 11;12(24):7620. doi: 10.3390/jcm12247620. J Clin Med. 2023. PMID: 38137688 Free PMC article. Review.
-
[Treatment of recurrent neovascular age-related macular degeneration with ranibizumab according to the PrONTO scheme].Ophthalmologe. 2013 Aug;110(8):740-5. doi: 10.1007/s00347-012-2717-6. Ophthalmologe. 2013. PMID: 23224125 German.
-
Health-related quality of life in patients with neovascular age-related macular degeneration: a prospective cohort study.J Patient Rep Outcomes. 2024 Aug 12;8(1):89. doi: 10.1186/s41687-024-00775-z. J Patient Rep Outcomes. 2024. PMID: 39133415 Free PMC article.
-
Brolucizumab for pre-treated patients with choroidal neovascularization and signs of tachyphylaxis to aflibercept and bevacizumab.Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2561-2566. doi: 10.1007/s00417-022-05634-5. Epub 2022 Mar 29. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35348844
-
Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration.Int Med Case Rep J. 2020 May 11;13:145-152. doi: 10.2147/IMCRJ.S252260. eCollection 2020. Int Med Case Rep J. 2020. PMID: 32494207 Free PMC article.
References
-
- Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optometry Physiol Opt. 1976;53:740–745. - PubMed
-
- McMonnies CW. Chart construction and letter legibility/readability. Ophthalmic Physiol Opt. 1999;19:498–506. - PubMed
-
- McMonnies CW, Ho A. Letter legibility and chart equivalence. Ophthalmic Physiol Opt. 2000;20:142–152. - PubMed
-
- Flom MC, Heath G, Takahashi E. Contour interaction and visual resolution: contralateral effect. Science. 1963;142:979–980. - PubMed
-
- Leinonen J, Laakkonen E, Laatikainen L. Random measurement error in visual acuity measurement in clinical settings. Acta Ophthalmol Scand. 2005;83:328–332. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials